151 related articles for article (PubMed ID: 36003907)
1. Characteristics, outcomes, and predictors of
Youn JC; Kim D; Kim IC; Lee HS; Choi JO; Jeon ES; Nishihara K; Kransdorf EP; Chang DH; Kittleson MM; Patel JK; Ramzy D; Esmailian F; Kobashigawa JA
Front Cardiovasc Med; 2022; 9():939275. PubMed ID: 36003907
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of heart transplant recipients with a pretransplant history of malignancy.
Youn JC; Kim D; Kim KA; Kim JJ; Kim IC; Lee HS; Choi JO; Jeon ES; Nishihara K; Kransdorf EP; Chang DH; Kittleson MM; Patel JK; Ramzy D; Esmailian F; Kobashigawa JA
Am J Transplant; 2022 Dec; 22(12):2942-2950. PubMed ID: 36050598
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Landscape of
Lee J; Yang AWJ; Chung LI; Yu J; Lee Y; Kim HS; Shin HJ; Choi YG; Bharat A; Chae YK
Transpl Int; 2023; 36():11552. PubMed ID: 37663524
[TBL] [Abstract][Full Text] [Related]
4. De novo malignancy in heart transplant recipients: A single center experience in Japan.
Kimura Y; Yanase M; Mochizuki H; Iwasaki K; Toda K; Matsuda S; Takenaka H; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Ikura MM; Wada K; Matsumoto Y; Seguchi O; Fukushima S; Fujita T; Kobayashi J; Fukushima N
J Cardiol; 2019 Mar; 73(3):255-261. PubMed ID: 30587457
[TBL] [Abstract][Full Text] [Related]
5. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Solid Organ Transplant Recipients With Preexisting Malignancies in Remission: A Systematic Review and Meta-Analysis.
Acuna SA; Huang JW; Daly C; Shah PS; Kim SJ; Baxter NN
Transplantation; 2017 Mar; 101(3):471-481. PubMed ID: 27101077
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
8. De Novo Malignancies After Liver Transplantation: Experience of a High-Volume Center.
Saglam K; Sahin TT; Ogut Z; Ince V; Usta S; Yilmaz S
J Gastrointest Cancer; 2022 Dec; 53(4):1020-1027. PubMed ID: 34778909
[TBL] [Abstract][Full Text] [Related]
9. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
Rivinius R; Helmschrott M; Ruhparwar A; Schmack B; Klein B; Erbel C; Gleissner CA; Akhavanpoor M; Frankenstein L; Darche FF; Thomas D; Ehlermann P; Bruckner T; Katus HA; Doesch AO
Drug Des Devel Ther; 2015; 9():93-102. PubMed ID: 25552900
[TBL] [Abstract][Full Text] [Related]
10. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
11. Malignancy after kidney transplantation: results of 400 patients from a single center.
Stratta P; Morellini V; Musetti C; Turello E; Palmieri D; Lazzarich E; Cena T; Magnani C
Clin Transplant; 2008; 22(4):424-7. PubMed ID: 18312442
[TBL] [Abstract][Full Text] [Related]
12. De Novo Malignancy After Living Donor Liver Transplantation: A Large Volume Experience.
Tiwari A; Saigal S; Choudhary NS; Saha S; Rastogi A; Bhangui P; Saraf N; Srinivasan T; Yadav SK; Gautam D; Nundy S; Soin AS
J Clin Exp Hepatol; 2020; 10(5):448-452. PubMed ID: 33029053
[TBL] [Abstract][Full Text] [Related]
13. The benefits of cancer screening in kidney transplant recipients: a single-center experience.
Kato T; Kakuta Y; Abe T; Yamanaka K; Imamura R; Okumi M; Ichimaru N; Takahara S; Nonomura N
Cancer Med; 2016 Feb; 5(2):153-8. PubMed ID: 26686199
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
Bhat M; Mara K; Dierkhising R; Watt KDS
Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
[TBL] [Abstract][Full Text] [Related]
15. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation.
Rivinius R; Helmschrott M; Ruhparwar A; Schmack B; Erbel C; Gleissner CA; Akhavanpoor M; Frankenstein L; Darche FF; Schweizer PA; Thomas D; Ehlermann P; Bruckner T; Katus HA; Doesch AO
Drug Des Devel Ther; 2016; 10():677-86. PubMed ID: 26937171
[TBL] [Abstract][Full Text] [Related]
17. De Novo Malignancies After Liver Transplantation: A Single Institution Experience.
Egeli T; Unek T; Ozbilgin M; Agalar C; Derici S; Akarsu M; Unek IT; Aysin M; Bacakoglu A; Astarcıoglu I
Exp Clin Transplant; 2019 Feb; 17(1):74-78. PubMed ID: 29237362
[TBL] [Abstract][Full Text] [Related]
18. Tumor Recurrence and Graft Survival in Renal Transplant Recipients with a History of Pretransplant Malignancy: A Matched Pair Analysis.
Becker F; Mehdorn AS; Getsopulos V; Schütte-Nütgen K; Reuter S; Suwelack B; Pascher A; Brockmann JG; Bahde R
J Clin Med; 2021 May; 10(11):. PubMed ID: 34071904
[TBL] [Abstract][Full Text] [Related]
19. High rates of de novo malignancy compromise post-heart transplantation survival.
Giuliano K; Canner JK; Etchill E; Suarez-Pierre A; Choi CW; Higgins RSD; Hsu S; Sharma K; Kilic A
J Card Surg; 2021 Apr; 36(4):1401-1410. PubMed ID: 33567114
[TBL] [Abstract][Full Text] [Related]
20. Post-Transplant Malignancy after Pediatric Kidney Transplantation: Retrospective Analysis of Incidence and Risk Factors in 884 Patients Receiving Transplants Between 1963 and 2015 at the University of Minnesota.
Serrano OK; Bangdiwala AS; Vock DM; Chinnakotla S; Dunn TB; Finger EB; Kandaswamy R; Pruett TL; Najarian JS; Matas AJ; Chavers BM
J Am Coll Surg; 2017 Aug; 225(2):181-193. PubMed ID: 28445794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
